2022 American Transplant Congress
CD209+ Macrophages-Mediated Immunosuppressive Effects in ADPKD Tissues
*Purpose: The intensity of maintenance immunosuppression required in autosomal dominant polycystic kidney disease (ADPKD) patients after renal transplantation is lower than average, suggesting a reduced…2022 American Transplant Congress
Simultaneous Robot-Assisted Bilateral Native Nephrectomy and Kidney Transplantation for Polycystic Kidney Disease
University of Maryland, Baltimore, Baltimore, MD
*Purpose: Simultaneous bilateral native nephrectomy (NNx) and kidney transplantation is the preferred treatment for patients with end-stage renal disease (ESRD) due to symptomatic polycystic kidney…2020 American Transplant Congress
Long-Term Pediatric Outcomes of Simultaneous vs. Sequential Liver-Kidney Transplantation: A Review of the UNOS Database
*Purpose: The long-term pediatric outcomes of simultaneous liver-kidney (SLK) transplantation and sequential liver and kidney transplantation, liver after kidney (LAK) and kidney after liver (KAL),…2020 American Transplant Congress
Effects of Kidney Transplantation on Cystogenesis in Kidneys Procured from a Deceased Donor with Autosomal Dominant Polycystic Kidney Disease
*Purpose: Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients are not routinely considered as kidney donors for renal transplantation. This is partially due to a concern…2020 American Transplant Congress
Simultaneous Laparoscopic Bilateral Native Nephrectomy and Open Kidney Transplantation in Patients with ESRD Due to ADPKD: A Single Center Experience
*Purpose: Patients with Autosomal Dominant Polycystic Kidney (ADPKD) progressing to end-stage renal disease (ESRD) often are symptomatic due to cystic kidneys and require surgical intervention.…2019 American Transplant Congress
Retroperitoneoscopic Native Nephrectomy in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease
*Purpose: Autosomal dominant polycystic kidney disease (ADPKD) leads to end stage kidney disease (ESKD) and the need for kidney transplantation (KTX). Native nephrectomy is required…2019 American Transplant Congress
Intracerebral Hemorrhage in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease: A Nationwide Analysis
*Purpose: This study aimed to evaluate the hospitalization rate for intracerebral hemorrhage (ICH) among renal transplant patients with adult polycystic kidney disease (ADPKD) and its…2018 American Transplant Congress
Pre-Existing Renal Cell Carcinomas in Patients with Polycystic Kidney Disease Undergoing Simultaneous Native Nephrectomy and Living Donor Kidney Transplantation
Due to the structural changes to the kidney that occur in polycystic kidney disease (PKD), imaging tests may not pick up pre-transplant renal cancers in…2018 American Transplant Congress
Risk Factors for Graft Failure in Kidney Transplant Recipients with Polycystic Kidney Disease
University of Wisconsin, Madison.
Background: Polycystic kidney disease (PKD) is the underlying renal disease in 15% of kidney transplant recipients (KTRs) in the US. Post-transplant outcomes and contributing factors…2018 American Transplant Congress
Native Kidney Volume Decreases after Kidney Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: Less Patients Need Nephrectomy?
1Nephrology, Hirosaki University, Hirosaki, Japan; 2Urology, Hirosaki University, Hirosaki, Japan.
Background.The clinical implication of kidney volume decline on abdominal symptom improvement after kidney transplantation in patients with autosomal dominant polycystic kidney disease (ADPKD). We investigated…
American Transplant Congress abstracts